metronidazole has been researched along with Endometritis in 38 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
Endometritis: Inflammation of the ENDOMETRIUM, usually caused by intrauterine infections. Endometritis is the most common cause of postpartum fever.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To estimate the efficacy of preoperative administration of intravaginal metronidazole for the prevention of postcesarean endometritis." | 9.09 | Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial. ( Kaunitz, AM; Pitt, C; Sanchez-Ramos, L, 2001) |
| "For the prevention of endometritis, we identified 23 studies that comprised 7097 women who were allocated to the following treatments: povidone-iodine (1%, 5%, 10%), chlorhexidine (0." | 9.01 | Povidone-iodine 1% is the most effective vaginal antiseptic for preventing post-cesarean endometritis: a systematic review and network meta-analysis. ( Kaunitz, AM; Kovacs, A; Mitta, M; Roeckner, JT; Sanchez-Ramos, L, 2019) |
| "The best way of treating pelvic inflammatory disease (PID) is not known." | 5.27 | Treating pelvic inflammatory disease with doxycycline and metronidazole or penicillin and metronidazole. ( Aine, R; Heinonen, PK; Lehtinen, M; Miettinen, A; Paavonen, J; Punnonen, R; Teisala, K, 1986) |
| " Because these organisms were strongly associated with endometritis, we recommend that all women with PID be treated with regimens that include metronidazole." | 5.11 | Bacterial vaginosis and anaerobic bacteria are associated with endometritis. ( Bass, DC; Haggerty, CL; Hillier, SL; Ness, RB, 2004) |
| "To estimate the efficacy of preoperative administration of intravaginal metronidazole for the prevention of postcesarean endometritis." | 5.09 | Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial. ( Kaunitz, AM; Pitt, C; Sanchez-Ramos, L, 2001) |
| "The efficacy and safety of two antibiotic combination (clindamycin + gentamycin [C + G] versus metronidazole + gentamycin [M + G]) have been compared in 45 in-patients suffering from pelvic inflammatory disease in a clinical prospective randomized trial." | 5.06 | [Prospective randomized study comparing the efficacy and tolerance of clindamycin-gentamycin versus metronidazole-gentamycin in acute utero-adnexal infections in hospitalized patients]. ( Cacault, JA; Engelman, P; Lebceuf, D; Rousset, D, 1987) |
| "For the prevention of endometritis, we identified 23 studies that comprised 7097 women who were allocated to the following treatments: povidone-iodine (1%, 5%, 10%), chlorhexidine (0." | 5.01 | Povidone-iodine 1% is the most effective vaginal antiseptic for preventing post-cesarean endometritis: a systematic review and network meta-analysis. ( Kaunitz, AM; Kovacs, A; Mitta, M; Roeckner, JT; Sanchez-Ramos, L, 2019) |
| "The aim of this retrospective study was to investigate whether oral antibiotics (doxycycline and metronidazole) combined with intrauterine perfusion (gentamicin and dexamethasone) are beneficial for patients with repeated implantation failure (RIF) and chronic endometritis (CE) to improve clinical pregnancy outcomes." | 4.31 | Combined oral antibiotics and intrauterine perfusion can improve in vitro fertilization and embryo transfer pregnancy outcomes in patients with chronic endometritis and repeated embryo implantation failure. ( Hang, F; Jin, Y; Li, J; Ma, N; Qin, A; Qin, W; Wang, J; Zhang, J, 2023) |
| "Serum levels of tobramycin were determined with an enzyme immunoassay technique in 20 puerperal women with postcesarean endometritis who were being treated with metronidazole-tobramycin." | 3.67 | Tobramycin dosing in the puerperal patient. ( Pastorek, JG; Phelan, M; Ragan, FA, 1987) |
| "To evaluate the role of anaerobic bacteria in postpartum endomyometritis, intravenous metronidazole was used as the sole initial therapy in 25 women with clinical signs of infection." | 3.66 | The role of anaerobic bacteria in postpartum endomyometritis. ( Ledger, WJ; Platt, LD; Yonekura, ML, 1979) |
| "Metronidazole was well tolerated by the mother and with this type of administration regimen, the fetus is not exposed to the drug." | 2.67 | Prevention of postcesarean infectious morbidity with a single dose of intravenous metronidazole. ( Garcia-Rojas, JM; Lozada-Leon, JD; Ruiz-Moreno, JA, 1991) |
| "Once the diagnosis of clinical chorioamnionitis has been established, delivery should be considered, regardless of the gestational age." | 2.66 | Management of clinical chorioamnionitis: an evidence-based approach. ( Conde-Agudelo, A; Garcia Sánchez, ÁJ; Jung, EJ; Romero, R, 2020) |
| "30 patients had severe acute pelvic inflammatory disease with peritonitis, 3 tubo-ovarian abscesses, 4 endomyometritis, and 2 posthysterectomy pelvic cellulitis." | 2.66 | Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections. ( Crombleholme, W; Dahrouge, D; DeKay, V; Hadley, WK; Landers, D; Ohm-Smith, M; Robbie, MO; Sweet, RL, 1986) |
| "When endometritis has been identified and cultures from the genital tract obtained." | 2.42 | Postpartum infection treatments: a review. ( Burstein, E; Chaim, W, 2003) |
| "The latter category includes pelvic inflammatory disease, pelvic thrombophlebitis, septic abortion, and premature rupture of the membranes." | 2.36 | Infections in the female genital tract. ( Gall, SA, 1983) |
| "Chronic endometritis was found in one-third of infertile women with RIF." | 1.46 | Live birth rate following oral antibiotic treatment for chronic endometritis in infertile women with repeated implantation failure. ( Ishikawa, T; Kitaya, K; Matsubayashi, H; Nishiyama, R; Takaya, Y; Takeuchi, T; Yamaguchi, K, 2017) |
| "mulieris in Turkish women with bacterial vaginosis, vulvo-vaginal abscesses, endometritis or salpingitis." | 1.33 | Mobiluncus species in gynaecological and obstetric infections: antimicrobial resistance and prevalence in a Turkish population. ( Bahar, H; Kocazeybek, B; Oçer, F; Torun, MM, 2005) |
| "Bacterial vaginosis is associated with adverse sequelae, including late miscarriage, preterm prelabour rupture of the membranes, chorioamnionitis, postpartum endometritis and preterm labour and delivery." | 1.30 | Bacterial vaginosis: its importance in obstetrics. ( Lamont, RF; Woodrow, N, 1998) |
| "15, independent of dosage (Tab." | 1.27 | Blood and milk concentrations of metronidazole in mothers and infants. ( Branebjerg, PE; Heisterberg, L, 1983) |
| "The best way of treating pelvic inflammatory disease (PID) is not known." | 1.27 | Treating pelvic inflammatory disease with doxycycline and metronidazole or penicillin and metronidazole. ( Aine, R; Heinonen, PK; Lehtinen, M; Miettinen, A; Paavonen, J; Punnonen, R; Teisala, K, 1986) |
| "Oral metronidazole was given as therapy in 25 women with the clinical diagnosis of a postpartum anaerobic soft tissue pelvic infection following a vaginal delivery." | 1.26 | A new approach to patients with suspected anaerobic postpartum pelvic infections. Transabdominal uterine aspiration for culture and metronidazole for treatment. ( Finegold, SM; Gee, CL; Ledger, WJ; Lewis, WP; Pollin, PA; Sutter, VL, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (44.74) | 18.7374 |
| 1990's | 6 (15.79) | 18.2507 |
| 2000's | 7 (18.42) | 29.6817 |
| 2010's | 3 (7.89) | 24.3611 |
| 2020's | 5 (13.16) | 2.80 |
| Authors | Studies |
|---|---|
| Shafique, L | 1 |
| Aqib, AI | 1 |
| Liang, Q | 1 |
| Qin, C | 1 |
| Ali, MM | 1 |
| Adil, M | 1 |
| Sarwar, Z | 1 |
| Saleem, A | 1 |
| Ajmal, M | 1 |
| Khan, A | 1 |
| Pan, H | 1 |
| Cui, K | 1 |
| Liu, Q | 1 |
| Ma, N | 1 |
| Li, J | 1 |
| Zhang, J | 1 |
| Jin, Y | 1 |
| Wang, J | 1 |
| Qin, W | 1 |
| Hang, F | 1 |
| Qin, A | 1 |
| Lambert, KA | 1 |
| Honart, AW | 1 |
| Hughes, BL | 1 |
| Kuller, JA | 1 |
| Dotters-Katz, SK | 1 |
| Conde-Agudelo, A | 1 |
| Romero, R | 1 |
| Jung, EJ | 1 |
| Garcia Sánchez, ÁJ | 1 |
| Gay, C | 1 |
| Hamdaoui, N | 1 |
| Pauly, V | 1 |
| Rojat Habib, MC | 1 |
| Djemli, A | 1 |
| Carmassi, M | 1 |
| Chau, C | 1 |
| Bretelle, F | 1 |
| Kitaya, K | 1 |
| Matsubayashi, H | 1 |
| Takaya, Y | 1 |
| Nishiyama, R | 1 |
| Yamaguchi, K | 1 |
| Takeuchi, T | 1 |
| Ishikawa, T | 1 |
| Roeckner, JT | 1 |
| Sanchez-Ramos, L | 2 |
| Mitta, M | 1 |
| Kovacs, A | 1 |
| Kaunitz, AM | 2 |
| Ijarotimi, AO | 1 |
| Badejoko, OO | 1 |
| Ijarotimi, O | 1 |
| Loto, OM | 1 |
| Orji, EO | 2 |
| Fasubaa, OB | 1 |
| Alekwe, LO | 1 |
| Kuti, O | 1 |
| Ogunniyi, SO | 1 |
| Tita, ATN | 1 |
| Rouse, DJ | 1 |
| Blackwell, S | 1 |
| Saade, GR | 1 |
| Spong, CY | 1 |
| Andrews, WW | 2 |
| Chaim, W | 1 |
| Burstein, E | 1 |
| MIRSALIM, M | 1 |
| Haggerty, CL | 1 |
| Hillier, SL | 1 |
| Bass, DC | 1 |
| Ness, RB | 1 |
| Bahar, H | 1 |
| Torun, MM | 1 |
| Oçer, F | 1 |
| Kocazeybek, B | 1 |
| Tita, AT | 1 |
| Cliver, SP | 1 |
| Goepfert, AR | 1 |
| Conner, M | 1 |
| Goldenberg, RL | 1 |
| Hauth, JC | 1 |
| Gall, SA | 1 |
| Emel'ianova, AI | 2 |
| Baltrashevich, AK | 1 |
| Kushnareva, MV | 1 |
| Komarovskaia, TP | 1 |
| Rukhadze, TG | 1 |
| Heisterberg, L | 1 |
| Branebjerg, PE | 1 |
| Gerstner, G | 1 |
| Kofler, E | 1 |
| Huber, J | 1 |
| Oyarzún, E | 1 |
| Gómez, R | 1 |
| Montiel, F | 1 |
| Cohen, RO | 1 |
| Colodner, R | 1 |
| Ziv, G | 1 |
| Keness, J | 1 |
| Woodrow, N | 1 |
| Lamont, RF | 1 |
| Lanta, S | 1 |
| Mention, JE | 1 |
| Pitt, C | 1 |
| Platt, LD | 1 |
| Yonekura, ML | 1 |
| Ledger, WJ | 2 |
| Gee, CL | 1 |
| Pollin, PA | 1 |
| Lewis, WP | 1 |
| Sutter, VL | 1 |
| Finegold, SM | 1 |
| Ruiz-Moreno, JA | 1 |
| Garcia-Rojas, JM | 1 |
| Lozada-Leon, JD | 1 |
| McGregor, JA | 1 |
| Christensen, FB | 1 |
| French, JI | 1 |
| Crombleholme, W | 1 |
| Landers, D | 1 |
| Ohm-Smith, M | 1 |
| Robbie, MO | 1 |
| Hadley, WK | 1 |
| DeKay, V | 1 |
| Dahrouge, D | 1 |
| Sweet, RL | 1 |
| Heinonen, PK | 1 |
| Teisala, K | 1 |
| Punnonen, R | 1 |
| Aine, R | 1 |
| Lehtinen, M | 1 |
| Miettinen, A | 1 |
| Paavonen, J | 1 |
| Gurtovoĭ, BL | 1 |
| Voropaeva, SD | 1 |
| Sokolova, IE | 1 |
| Stephens, LR | 1 |
| Slee, KJ | 1 |
| Koinzer, G | 1 |
| Walter, S | 1 |
| Peschke, KH | 1 |
| Wecke, WD | 1 |
| Lebceuf, D | 1 |
| Rousset, D | 1 |
| Cacault, JA | 1 |
| Engelman, P | 1 |
| Pastorek, JG | 1 |
| Ragan, FA | 1 |
| Phelan, M | 1 |
| Monnier, JC | 1 |
| Monif, GR | 1 |
| Gaudin, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial[NCT03871491] | Phase 3 | 34,000 participants (Anticipated) | Interventional | 2020-09-01 | Active, not recruiting | ||
| Peri-operative Cefazolin Prophylaxis at Time of Cesarean Delivery in the Obese Gravida[NCT01904500] | Phase 1 | 26 participants (Anticipated) | Interventional | 2013-08-31 | Completed | ||
| Cesarean Section Optimal Antibiotic Prophylaxis Trial[NCT01235546] | 2,013 participants (Actual) | Interventional | 2011-05-31 | Completed | |||
| Azithromycin-based Extended-spectrum Prophylaxis in Scheduled Cesarean Deliveries[NCT03960970] | Phase 2 | 800 participants (Anticipated) | Interventional | 2019-09-15 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Any diagnosis of pyloric stenosis based on clinical presentation and radiological and/or surgical confirmation (NCT01235546)
Timeframe: up to 3 months after birth
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo and Standard of Care | 1 |
| Azithromycin and Standard of Care | 2 |
(NCT01235546)
Timeframe: Up to 6 weeks after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo With Standard Prophylaxis | 81 |
| Azithromycin (Zithromax) With Standard Prophylaxis | 51 |
Maternal postpartum use of antibiotics (NCT01235546)
Timeframe: Up to 6 weeks after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo and Standard of Care | 166 |
| Azithromycin and Standard of Care | 126 |
Maternal postpartum unscheduled visit or readmission to the hospital (NCT01235546)
Timeframe: Up to 6 weeks after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo and Standard of Care | 123 |
| Azithromycin and Standard of Care | 83 |
All maternal serious adverse events (NCT01235546)
Timeframe: Up to 6 weeks after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo and Standard of Care | 29 |
| Azithromycin and Standard of Care | 15 |
Neonates who are admitted to the NICU due to morbidities diagnosed from birth and up to three months of life. Morbidities as defined in the Neonatal morbidities outcome measure. (NCT01235546)
Timeframe: Up to 3 months after birth
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo and Standard of Care | 169 |
| Azithromycin and Standard of Care | 171 |
morbidities include: death, Respiratory Distress Syndrome (RDS), Bronchopulmonary Dysplasia (BPD), Periventricular Leukomalacia (PVL) suspected or proven sepsis, Necrotizing Enterocolitis (NEC) Intraventricular Hemorrhage (IVH) and systemic inflammatory response syndrome (NCT01235546)
Timeframe: Up to 3 months after birth
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo and Standard of Care | 135 |
| Azithromycin and Standard of Care | 146 |
(NCT01235546)
Timeframe: Up to 3 months after birth
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo With Standard Prophylaxis | 43 |
| Azithromycin (Zithromax) With Standard Prophylaxis | 39 |
Composite for all neonatal serious adverse events (NCT01235546)
Timeframe: Up to 3 months after birth
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo and Standard of Care | 5 |
| Azithromycin and Standard of Care | 7 |
Endometritis was defined as the presence of at least two of the following signs with no other recognized cause: fever (temperature of at least 38°C [100.4°F]), abdominal pain, uterine tenderness, or purulent drainage from the uterus. Wound infection was defined as the presence of either superficial or deep incisional surgical-site infection characterized by cellulitis or erythema and induration around the incision or purulent discharge from the incision site with or without fever and included necrotizing fasciitis. Wound hematoma, seroma, or breakdown alone in the absence of the preceding signs did not constitute infection. (NCT01235546)
Timeframe: Up to 6 weeks after delivery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 119 |
| Azithromycin | 62 |
6 reviews available for metronidazole and Endometritis
| Article | Year |
|---|---|
Management of clinical chorioamnionitis: an evidence-based approach.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, L | 2020 |
Povidone-iodine 1% is the most effective vaginal antiseptic for preventing post-cesarean endometritis: a systematic review and network meta-analysis.
Topics: Anti-Infective Agents, Local; Cesarean Section; Cetrimonium; Chlorhexidine; Endometritis; Female; Hu | 2019 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cefazolin; Cesarean Section; Endometrit | 2009 |
Postpartum infection treatments: a review.
Topics: 4-Quinolones; Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infect | 2003 |
Infections in the female genital tract.
Topics: Abortion, Septic; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; En | 1983 |
[Bacterial vaginosis II. Related pathology and therapy].
Topics: Anti-Bacterial Agents; Chorioamnionitis; Clindamycin; Endometritis; Female; Humans; Metronidazole; O | 1995 |
11 trials available for metronidazole and Endometritis
| Article | Year |
|---|---|
Comparison of short versus long term antibiotic prophylaxis in elective caesarean section at the Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cesarean Section; Cloxacillin; Drug Admin | 2013 |
Comparison of ceftriaxone versus triple drug regimen in the prevention of cesarean section infectious morbidities.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftriaxone; Cesarean Section; Clo | 2008 |
Bacterial vaginosis and anaerobic bacteria are associated with endometritis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteria, Anaerobic; Endometritis; Female; Humans; Metroni | 2004 |
Clinical trial of interconceptional antibiotics to prevent preterm birth: subgroup analyses and possible adverse antibiotic-microbial interaction.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Bacterial Infections; Double-Bli | 2007 |
[Perioperative metronidazole-prophylaxis for cesarian section (author's transl].
Topics: Adult; Cesarean Section; Endometritis; Female; Humans; Metronidazole; Pregnancy; Surgical Wound Infe | 1980 |
Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial.
Topics: Administration, Intravaginal; Adult; Anti-Infective Agents; Cesarean Section; Double-Blind Method; E | 2001 |
Prevention of postcesarean infectious morbidity with a single dose of intravenous metronidazole.
Topics: Adult; Cesarean Section; Endometritis; Female; Humans; Infusions, Intravenous; Metronidazole; Postop | 1991 |
Intramuscular imipenem/cilastatin treatment of upper reproductive tract infection in women: efficacy and use characteristics.
Topics: Cesarean Section; Cilastatin; Cilastatin, Imipenem Drug Combination; Consumer Behavior; Costs and Co | 1991 |
Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cellulitis; Drug Therapy, Combination; Endometritis; Female; | 1986 |
[Prospective randomized study comparing the efficacy and tolerance of clindamycin-gentamycin versus metronidazole-gentamycin in acute utero-adnexal infections in hospitalized patients].
Topics: Adolescent; Clindamycin; Clinical Trials as Topic; Drug Therapy, Combination; Endometritis; Female; | 1987 |
[Comparative clinical study between Rocephin (Roche) and doxycycline, amoxycillin, erythromycin and amoxycillin + metronidazole combination in gynecology].
Topics: Abscess; Adult; Aged; Amoxicillin; Breast Diseases; Cefotaxime; Ceftriaxone; Clinical Trials as Topi | 1985 |
21 other studies available for metronidazole and Endometritis
| Article | Year |
|---|---|
Genomic and Therapeutic Analyses of
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Cattle; | 2022 |
Combined oral antibiotics and intrauterine perfusion can improve in vitro fertilization and embryo transfer pregnancy outcomes in patients with chronic endometritis and repeated embryo implantation failure.
Topics: Anti-Bacterial Agents; Chronic Disease; Dexamethasone; Doxycycline; Embryo Implantation; Embryo Tran | 2023 |
Antibiotic Recommendations After Postpartum Uterine Exploration or Instrumentation.
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Endometritis; Female; Humans; | 2023 |
Impact of antibiotic treatment for chronic endometritis on unexplained recurrent pregnancy loss.
Topics: Abortion, Habitual; Adult; Analysis of Variance; Anti-Bacterial Agents; Birth Rate; Chronic Disease; | 2021 |
Live birth rate following oral antibiotic treatment for chronic endometritis in infertile women with repeated implantation failure.
Topics: Administration, Oral; Adult; Birth Rate; Chronic Disease; Ciprofloxacin; Endometritis; Female; Human | 2017 |
[EXPERIMENTAL STUDIES ON THE ASCENT OF TRICHOMONAS INFECTION IN THE FEMALE GENITALIA].
Topics: Drug Therapy; Endometritis; Female; Genitalia, Female; Humans; Metronidazole; Pelvic Inflammatory Di | 1964 |
Mobiluncus species in gynaecological and obstetric infections: antimicrobial resistance and prevalence in a Turkish population.
Topics: Abscess; Actinomycetales Infections; Anaerobiosis; Anti-Bacterial Agents; Cross-Sectional Studies; C | 2005 |
[Etiologic aspects of puerperal endometritis and its etiotropic treatment].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Endometritis; Female; | 1983 |
Blood and milk concentrations of metronidazole in mothers and infants.
Topics: Breast Feeding; Endometritis; Female; Humans; Infant, Newborn; Metronidazole; Milk, Human; Pregnancy | 1983 |
Isolation and antimicrobial susceptibility of obligate anaerobic bacteria recovered from the uteri of dairy cows with retained fetal membranes and postparturient endometritis.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Cattle; Cattle Diseases; Ciprofloxacin; Clindam | 1996 |
Bacterial vaginosis: its importance in obstetrics.
Topics: Abortion, Spontaneous; Anti-Infective Agents; Chorioamnionitis; Endometritis; Female; Humans; Metron | 1998 |
[Leukorrhea: diagnostic trends].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitricho | 1999 |
The role of anaerobic bacteria in postpartum endomyometritis.
Topics: Anaerobiosis; Bacteria; Drug Resistance, Microbial; Endometritis; Evaluation Studies as Topic; Femal | 1979 |
A new approach to patients with suspected anaerobic postpartum pelvic infections. Transabdominal uterine aspiration for culture and metronidazole for treatment.
Topics: Abdomen; Adult; Anaerobiosis; Bacteria; Endometritis; Female; Humans; Metronidazole; Pregnancy; Puer | 1976 |
Treating pelvic inflammatory disease with doxycycline and metronidazole or penicillin and metronidazole.
Topics: Adult; Chlamydia trachomatis; Doxycycline; Drug Therapy, Combination; Endometritis; Female; Humans; | 1986 |
[Present-day etiology and antibacterial therapy of puerperal endometritis].
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Endometritis; Female; Humans | 1988 |
Metronidazole for the treatment of bovine pyometra.
Topics: Ampicillin; Animals; Bacterial Infections; Cattle; Cattle Diseases; Drug Therapy, Combination; Endom | 1987 |
[Prevention of infection with metronidazole in abortion induced by PGF2 alpha].
Topics: Abortion, Induced; Adolescent; Adult; Dinoprost; Endometritis; Female; Humans; Metronidazole; Pelvic | 1986 |
Tobramycin dosing in the puerperal patient.
Topics: Cesarean Section; Drug Therapy, Combination; Endometritis; Female; Humans; Kinetics; Metronidazole; | 1987 |
[Efficacy of a peroperative cefuroxime-metronidazole combination for the prevention of infections after cesarean section].
Topics: Adult; Bacterial Infections; Cefuroxime; Cephalosporins; Cesarean Section; Drug Therapy, Combination | 1987 |
Short-term failure of IUD removal to alter bacterial flora in a patient with chronic anaerobic endometritis.
Topics: Adult; Bacteria, Anaerobic; Bacterial Infections; Endometritis; Female; Humans; Intrauterine Devices | 1986 |